Last update 13 Jul 2024

GSK-6097608

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
GSK 6097608, GSK’608, GSK’608 CD96
Target
Mechanism
CD96 inhibitors(CD96 molecule inhibitors)
Therapeutic Areas
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 2
US
24 Jan 2019
NeoplasmsPhase 2
AU
24 Jan 2019
NeoplasmsPhase 2
CA
24 Jan 2019
NeoplasmsPhase 2
DK
24 Jan 2019
NeoplasmsPhase 2
FR
24 Jan 2019
NeoplasmsPhase 2
DE
24 Jan 2019
NeoplasmsPhase 2
IT
24 Jan 2019
NeoplasmsPhase 2
NL
24 Jan 2019
NeoplasmsPhase 2
PL
24 Jan 2019
NeoplasmsPhase 2
RO
24 Jan 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free